James is a co-founder and Chief Scientific Officer at Helix. Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by our proprietary Exome+ ® assay, Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information.

Prior to Helix, James was a faculty member at Duke University where he focused on
translational genomics and machine learning methodologies for EMRs. James has explored research topics in population genetics, Mendelian genomics, and computational psychiatry. James holds an M.D. and Ph.D. from the Baylor College of Medicine. He also received a B.S. and M.S. in Chemical Engineering from Stanford University.